Skip to main content

Peter Wolpert elected to the MedUniverse Board

Press Release   •   Jan 18, 2017 10:48 CET

On November 25, 2016 the Extraordinary General Meeting of MedUniverse AB voted in favor of the proposal to elect Peter Wolpert as a new board member.

After the meeting, the board has the following composition:

  • Fredrik Sjödin (Chairman)
  • Björn Littorin
  • Pär Nordström
  • Håkan Åström
  • Anna Omstedt
  • Peter Wolpert

Mr Wolpert, M.Sc. Eng., M.Sc. Econ., has extensive experience in health care and co-founded Moberg Pharma AB (publ) in March 2006 and serves as its Chief Executive Officer and President. He has twenty years’ experience of strategy/business development, financing and management of start-ups. He serves as Chairman of Viscogel AB. Previous experience includes CEO of Athera Biotechnologies AB and as a consultant at McKinsey & Co.

For further information, please contact:
Anna Omstedt, CEO and Founding Partner of MedUniverse AB
Phone: +46 70 772 6364 
E-mail: anna.omstedt@meduniverse.com

MedUniverse AB, based in Stockholm, offers the life science industry an easy-to-use patient case software bridging the information gap to healthcare professionals (HCPs). In the long run, aggregated results from HCP engagement will enhance well-informed decisions and thus improve patient outcomes. MedUniverse AB is owned by private investors, Board and Management. For further information please visit: www.meduniverse.com.